Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice.
Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice. Acta Neuropathol Commun. 2022 01 29; 10(1):11.